OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk
Matthew Nayor, Kemar Brown, Ramachandran S. Vasan
Circulation Research (2021) Vol. 128, Iss. 2, pp. 287-303
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

The Effect of Dietary Polyphenols on Vascular Health and Hypertension: Current Evidence and Mechanisms of Action
Giuseppe Grosso, Justyna Godos, Walter Currenti, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 545-545
Open Access | Times Cited: 95

A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis
Weizhi Wang, Chao Liu, Jinque Luo, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 10, pp. 2119-2133
Closed Access | Times Cited: 21

The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Sarah Zaman, Jason H. Wasfy, Vikas Kapil, et al.
The Lancet (2025)
Closed Access | Times Cited: 3

The crosstalk between Nrf2 and NF-κB pathways in coronary artery disease: Can it be regulated by SIRT6?
Eman Casper
Life Sciences (2023) Vol. 330, pp. 122007-122007
Closed Access | Times Cited: 36

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease
Xiaolan Zhao, Zhanxue Cao, Ke-Di Li, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1

Research Progress and Clinical Translation Potential of Coronary Atherosclerosis Diagnostic Markers from a Genomic Perspective
Hanxiang Liu, Yuchen Zhang, Yueyan Zhao, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 98-98
Open Access | Times Cited: 1

Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populations
Nilanjana Sadhu, Rinkoo Dalan, Pritesh Jain, et al.
Nature Cardiovascular Research (2025)
Closed Access | Times Cited: 1

Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
Giovanna Petrucci, Alessandro Rizzi, Duaa Hatem, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1408-1408
Open Access | Times Cited: 38

Recent advances of traditional Chinese medicine for the prevention and treatment of atherosclerosis
Wenbing Zhi, Yang Liu, Xiumei Wang, et al.
Journal of Ethnopharmacology (2022) Vol. 301, pp. 115749-115749
Open Access | Times Cited: 35

ECM Microenvironment in Vascular Homeostasis: New Targets for Atherosclerosis
Lu Zhang, Qianqian Feng, Wei Kong
Physiology (2024) Vol. 39, Iss. 5, pp. 324-344
Closed Access | Times Cited: 7

CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques
Qimin Wu, Wei Pan, Guifu Wu, et al.
Atherosclerosis (2023) Vol. 369, pp. 17-26
Open Access | Times Cited: 16

Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases
Giuditta Benincasa, Rosa Suades, Teresa Padró, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 8, pp. 758-769
Closed Access | Times Cited: 14

Ginsenoside Rb1 in cardiovascular and cerebrovascular diseases: A review of therapeutic potentials and molecular mechanisms
Y Song, Chen Chen, Wei Li
Chinese Herbal Medicines (2024) Vol. 16, Iss. 4, pp. 489-504
Open Access | Times Cited: 6

Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis
Qiyu Li, Zheyong Huang, Zhiqing Pang, et al.
Chemical Engineering Journal (2022) Vol. 452, pp. 138992-138992
Closed Access | Times Cited: 21

Ketone Bodies as Metabolites and Signalling Molecules at the Crossroad between Inflammation and Epigenetic Control of Cardiometabolic Disorders
Nadia Bendridi, Anna Selmi, Aneta Balcerczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14564-14564
Open Access | Times Cited: 21

Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
Ming Zhang, Zhongjian Xie, Haijiao Long, et al.
Materials Today Bio (2022) Vol. 14, pp. 100236-100236
Open Access | Times Cited: 20

Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
Anagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 49-89
Open Access | Times Cited: 13

The “Common Soil Hypothesis” Revisited—Risk Factors for Type 2 Diabetes and Cardiovascular Disease
Lilian Fernandes Silva, Jagadish Vangipurapu, Markku Laakso
Metabolites (2021) Vol. 11, Iss. 10, pp. 691-691
Open Access | Times Cited: 27

Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms
Daniel Gonzalez Izundegui, Matthew Nayor
Current Diabetes Reports (2022) Vol. 22, Iss. 2, pp. 65-76
Open Access | Times Cited: 17

Potential therapeutic value of dietary polysaccharides in cardiovascular disease: Extraction, mechanisms, applications, and challenges
Qiqi Jin, Bin Lin, Lingeng Lu
International Journal of Biological Macromolecules (2025) Vol. 296, pp. 139573-139573
Closed Access

Lysosome Functions in Atherosclerosis: A Potential Therapeutic Target
Zhengchao Wang, Xiang Li, Alexandra K. Moura, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 183-183
Open Access

Endothelial Krüppel-like factor 2/4: Regulation and function in cardiovascular diseases
Jing Gao, Hongjie Pan, Xiaogang Guo, et al.
Cellular Signalling (2025), pp. 111699-111699
Closed Access

Page 1 - Next Page

Scroll to top